Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Due to Alzheimer's Disease (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06400368
What this trial is testing

Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
NeuroVision Imaging 200
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Testing effectiveness (Phase 2)Looking for participantsNCT07553338
What this trial is testing

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseAlzheimer's Disease
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70
Not applicableLooking for participantsNCT07224607
What this trial is testing

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Who this might be right for
Alzheimer's Disease
Cedars-Sinai Medical Center 45
Early research (Phase 1)Study completedNCT06114745
What this trial is testing

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)
Atridia Pty Ltd. 2
Testing effectiveness (Phase 2)Study completedNCT02337907
What this trial is testing

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 329
Early research (Phase 1)Study completedNCT05644977
What this trial is testing

A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

Who this might be right for
Healthy ParticipantsAlzheimer's Disease Dementia
AbbVie 17
Early research (Phase 1)Ended earlyNCT06247345
What this trial is testing

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Who this might be right for
Alzheimer Disease
Alzheimer's Disease Expert Lab (ADEL), Inc. 42
Early research (Phase 1)Study completedNCT04931459
What this trial is testing

Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 65
Not applicableUnknownNCT06508268
What this trial is testing

Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseMCI Due to ADDementia Alzheimers
Hanze University of Applied Sciences Groningen 208
Testing effectiveness (Phase 2)Looking for participantsNCT06847321
What this trial is testing

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease Due to P. Gingivalis
Lighthouse Pharmaceuticals, Inc. 300
Post-approval studies (Phase 4)Study completedNCT01478633
What this trial is testing

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 102
Not applicableStudy completedNCT05544201
What this trial is testing

Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease

Who this might be right for
Brain StimulationAlzheimer DiseasetACS+3 more
Chinese University of Hong Kong 99
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Not applicableUnknownNCT05732519
What this trial is testing

Turkish Speech Analysis Development Study

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
mihrimah ozturk 180
Testing effectiveness (Phase 2)UnknownNCT04141150
What this trial is testing

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics, LLC 130
Not applicableStudy completedNCT03175874
What this trial is testing

Autophagy and Pathological Aging

Who this might be right for
Osteoporosis
Centre Hospitalier Universitaire de Nice 82
Testing effectiveness (Phase 2)WithdrawnNCT02667496
What this trial is testing

Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Dementia Alzheimer's Type
Sanofi
Early research (Phase 1)Study completedNCT04749563
What this trial is testing

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia of Alzheimer Type
IGC Pharma, LLC 12
Next Page